Christopher Glancy | White & Case LLP International Law Firm, Global Law Practice
Christopher Glancy
Christopher Glancy

Christopher Glancy

Partner, New York


Chris Glancy is an intellectual property lawyer with a broad range of experience. He has litigated and tried cases involving patents, trademarks, copyrights, trade secrets, and false advertising, as well as contract disputes.

As a member of our global Data, Privacy and Cyber Security Group, Chris counsels clients on U.S. data privacy law. He also keeps abreast of the latest developments in IP law relating to the internet and e-commerce and regularly counsels clients on these issues.

He has represented clients in a wide array of industries, including the pharmaceutical, music, television, sports, ecommerce, publishing, finance, automotive, jewelry, and telecommunications industries.

Bars and Courts

  • New York State Bar
  • US District Court for the Southern District of New York
  • US Court of Appeals for the Federal Circuit
  • US Court of Appeals for the Second Circuit
  • US Court of Appeals for the Eighth Circuit
  • US Supreme Court


  • JD, New York University School of Law, Executive Editor, Annual Survey of American Law
  • BA, Rutgers University


  • English


UCB, patent infringement, 2013-2015

Representation of pharma company UCB in a patent infringement action brought by Apotex in the Southern District of Florida. In this post-Therasense case, the court ruled, after a three-day bench trial on UCB's equitable defenses, that the patent was unenforceable due to multiple acts of inequitable conduct. The Federal Circuit affirmed. The district court also ruled that the patent was invalid as indefinite, and that Apotex's claims were otherwise barred by judicial estoppel, prosecution disclaimer, and laches, and awarded UCB over $6 million in fees and expenses.

UCB, patent infringement, 2015

Defending UCB in a patent infringement action concerning its arthritis medication Cimzia. The court granted our motion for summary judgment based on our construction of the term "monoclonal antibody" in the patent.

Pfizer, contract litigation, 2015

Defending Pfizer in breach of contract litigation brought by NYU in New York state court. NYU sought royalties on Pfizer's cancer drug Xalkori under a 1996 research and development agreement. The court granted our motion to dismiss NYU's claim with prejudice.

Experian, trademark infringement, 2009-2010

Representation of credit reporting agency Experian in a trademark infringement, false advertising and antitrust litigation brought by Fair Isaac in the District of Minnesota. The court granted our client's motion for summary judgment on Fair Isaac's false advertising and antitrust claims. A jury trial on the trademark claims followed, and we prevailed. The jury found that Fair Isaac's alleged trademark in its scoring scale "300-850" did not acquire secondary meaning and that Fair Isaac committed fraud on the Trademark Office in procuring its registration. Separately, the court ruled that Fair Isaac had failed to prove its keyword advertising trademark claims. The Eighth Circuit affirmed.

Google, patent infringement, 2012-2014

Representation of Google and other technology companies in three amicus briefs filed in the Federal Circuit in the 'Apple v. Samsung' patent litigation.

Online retailer trademark matters, 2014-ongoing

Advising world-leading online retailer on various trademark and keyword advertising matters.

Zales, false advertising, 2013

Representation of Zales in a false advertising litigation brought by rival Sterling Jewelers, the owner of Kaye Jewelers and Jared. We defeated Sterling's motion for preliminary injunction, which had the potential to seriously disrupt Zales' entire advertising campaign at the height of the holiday season. The case later settled on terms favorable to our client.

Pharma trademark and copyright counselings, 2012-ongoing

Advising pharma clients Pfizer, Novo Nordisk and Lundbeck on trademark and copyright matters.

Verizon Wireless, false advertising, 2009

Representation of Verizon Wireless in false advertising disputes against AT&T Mobility in federal court. The case concerned both parties' advertising claims regarding network coverage, quality and reliability.

ESPN, trademark infringement, 2005

Representation of ESPN in a trademark infringement action brought by Playmakers LLC, a sports agency, in federal court in Washington. The plaintiff claimed that the title of our client's TV series, Playmakers, infringed its mark. The district court granted our motion for summary judgment of noninfringement, which was affirmed by the Ninth Circuit.

Speaking Engagements

"White & Case Digital Health Conference", 2014:
Palo Alto, CA
, (Panelist)

"'Viacom v. YouTube': The Second Circuit construes the DMCA safe-harbor for user uploaded content", 2012: Law Seminars Int'l


  • A Survey of 2010 Dilution Cases: Comparison of the Standard Used to Evaluate the Similarity of the Marks in Dilution by Blurring Decisions, Inside the Minds: Recent Trends in Trademark Protection, Aspatore, 2011 ed., (co-author)
  • The Trademark Dilution Revision Act of 2006 Clarification and Expansion of the Fair Use Exception, MLRC Media Law Letter, October 31, 2006, (co-author)
  • Searching for Clarity: Trademark Disputes Over Keyword Advertising Have Returned Confusing Results, IP Law & Business, January 2006
  • End of the Domain Goldrush? An Overview of the Anticybersquatting Consumer Protection Act, Internet Law & Business, January 2000